Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Integrating Online Weight Management With Primary Care Support (PROPS)

9 de outubro de 2020 atualizado por: Heather J. Baer, Brigham and Women's Hospital

Integrating Online Weight Management With Primary Care Support: Patient-Centered Strategies for Addressing Overweight and Obesity in Primary Care

The goal of this project is to adapt an evidence-based online weight management program and integrate it with population management support from primary care practices. Investigators then will conduct a three-arm, cluster-randomized trial to compare the effectiveness of 1) the combined intervention (online weight management program plus population management support) with 2) the stand-alone online weight management program and with 3) usual care, among overweight and obese primary care patients with type 2 diabetes or hypertension. The specific aims are:

  1. a. To adapt an online weight management program and integrate it with population management support, incorporating input from patients, primary care clinicians, and other stakeholders; afterward, investigators will acquire feedback on the positive and negative aspects of the intervention.

    b. To compare the effectiveness of the combined intervention (online weight management program plus population management support) with the stand-alone online program and with usual care.

    Hypothesis 1: The combined intervention will lead to greater weight loss at 12 months compared with the stand-alone online program and with usual care.

  2. To identify mediators of the combined intervention and the stand-alone online program.

    Hypothesis 2: The effects of the combined intervention and the stand-alone online program on weight loss will be mediated by patients' level of engagement, changes in self-efficacy, and changes in diet and physical activity.

  3. To explore whether the effectiveness of the combined intervention and the stand-alone weight management program varies by patient characteristics.

Hypothesis 3: The interventions will be more effective among patients who are younger, white, and higher socioeconomic status, although the population management strategy may help to reduce these differences.

Visão geral do estudo

Descrição detalhada

Focus Groups and Key Informant Interviews:

Focus groups will be conducted with 5 to 7 patients at the beginning of the study to obtain their feedback about an online program and the population health management support strategy. To be eligible for the focus groups, patients must have a Brigham and Women's Hospital (BWH) primary care clinician, be between ages 20-70 years old, and have a recent BMI (in the past year) between approximately 27 and 40 kg/m2. They should also be interested in weight management and/or motivated to lose weight.

Phone interviews will be conducted at the end of the study to solicit feedback on the BMIQ program and the population health management intervention. Patients in the PROPS Study who are assigned to the online program or combined intervention arm, reach the 18-month timepoint, and complete the final study survey are eligible and will be invited to participate.

Key Informant Interviews will be conducted at the beginning and the end of the study. To be eligible, the key informants must be clinicians or other staff who provide services to patients at one of the participating BWH primary care practices. There are a total of 165 clinicians in these practices, including staff physicians, residents or fellows, and nurse practitioners or physician assistants. Approximately 7 clinicians at each timepoint will be recruited as key informants and will also be asked to complete electronic surveys during the trial.

After adapting the online weight management program and integrating it with the population management support strategy based on our focus groups and key informant interviews, investigators will conduct a three-arm cluster-randomized trial to compare the effectiveness of the combined intervention (online weight management program plus population management support) with the stand-alone online weight management program and with usual care. This will be a pragmatic clinical trial conducted in approximately 14 BWH primary care practices. To be eligible for the trial, patients must have an upcoming scheduled visit at a BWH primary care practice, BMI between 27 and 39.9 kg/m2 at enrollment, and a diagnosis of type 2 diabetes or hypertension. They also must be between ages 20 and 70 (inclusive) at enrollment, speak English or Spanish, and have access the Internet using a computer, tablet, or smart phone. Finally, patients must be motivated to lose weight. Investigators plan to recruit a total of 840 patients for the study (280 per arm). Patients who enroll in the trial will attend regular primary care visits at their practices and also will complete surveys by e-mail, regular mail, or phone.

Tipo de estudo

Intervencional

Inscrição (Real)

840

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02115
        • Brigham and Women's Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

20 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. upcoming or recent visit at primary care practice affiliated with Brigham and Women's Hospital
  2. age 20-70
  3. diagnosis of type 2 diabetes and/or hypertension
  4. BMI >= 27 and < 40 kg/m2
  5. motivated to lose weight
  6. valid email address and access the Internet using a computer, tablet, or smartphone
  7. English or Spanish-speaking

Exclusion Criteria:

1. on insulin for treatment of their diabetes 2. MI, stroke, or atherosclerotic cardiovascular disease (ASCVD) procedure in last 6 months 3. Unstable angina 4. Currently pregnant or planning to become pregnant during the study period 5. Currently lactating 5. Has had bariatric surgery or planning to have bariatric surgery 6. >5% weight loss in the last 6 months 7. Severe psychiatric illness or impaired mental status 8. Active or diagnosed history of and/or self-reported history of eating disorders 9. Self-reported average consumption of > 14 alcoholic drinks/week 10. Any serious medical condition that would affect weight loss or for which weight loss is contraindicated, including active cancer (excluding non-melanoma skin cancer) or currently being treated for cancer, end stage renal disease (ESRD) on dialysis, etc.

11. On comfort care measures, hospice, or in nursing home 12. Participating in a contra-indicative research study 13. Use of prescription or over-the-counter weight loss medications or an all-liquid diet program in the last 6 months or currently 14. Any other medical contraindication for weight loss or physical activity, or any other reason that the PCP or their delegate (e.g., LPN or RN) did not deem the patient appropriate for the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Online Program Only
Patients will use an online weight management program called BMIQ, with minimal additional support.
Patients who are enrolled in one of the two arms using the online weight management program (BMIQ) will complete structured educational sessions, follow specific calorie goals and meal plans, participate in self-monitoring activities (i.e., regular tracking of weight, diet, and physical activity), and interact with other features of the program.
Experimental: Combined Intervention
Patients will use an online weight management program called BMIQ, but will also receive additional monitoring and support from a population health manager who works with their primary care practices.
Patients who are enrolled in one of the two arms using the online weight management program (BMIQ) will complete structured educational sessions, follow specific calorie goals and meal plans, participate in self-monitoring activities (i.e., regular tracking of weight, diet, and physical activity), and interact with other features of the program.
Patients will receive weight-related population health management support from their primary care practice; their online weight management program data will be monitored by the population health manager, who will conduct outreach with patients at designated points according to the protocol.
Sem intervenção: Usual Care
Patients will continue receiving usual care but will also be mailed some general written information about weight management (very minimal intervention.)

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Body Weight at 12 Months
Prazo: 12 months after the initial primary care visit
change in body weight from enrollment to 12 months
12 months after the initial primary care visit

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Body Weight at 6 Months
Prazo: 6 months after the initial primary care visit
change in body weight from enrollment to 6 months
6 months after the initial primary care visit
Change in Body Weight at 18 Months
Prazo: 18 months after the initial primary care visit
change in body weight from enrollment to 18 months
18 months after the initial primary care visit
Percent Weight Change at 6 Months
Prazo: 6 months after the initial primary care visit
Percent weight change from enrollment to 6 months
6 months after the initial primary care visit
Percent Weight Change at 12-Months
Prazo: 12 months after the initial primary care visit
Percent weight change from enrollment to 12 months
12 months after the initial primary care visit
Percent Weight Change at 18-Months
Prazo: 18 months after the initial primary care visit
Percent weight change from enrollment to 18 months
18 months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 6 Months
Prazo: 6-months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss from enrollment to 6 months
6-months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 12-months
Prazo: 12 months after the initial primary care visit
Percent of Patients with at least 5% weight loss from enrollment to 12 months
12 months after the initial primary care visit
Percent of Patients With at Least 5% Weight Loss at 18 Months
Prazo: 18-months after the initial primary care visit
Percent of Patients With at least 5% weight loss from enrollment to 18 months
18-months after the initial primary care visit
Changes in Self-efficacy Around Weight Loss at 12 Months
Prazo: 12 months after initial primary care visit
Changes in self-efficacy around weight loss at 12 months Self-efficacy will be assessed by asking patients to rate their confidence in their ability to lose weight on a scale from 1 ("not at all confident") to 10 ("very confident"). A rank of 1-7 reflects low self-efficacy, while 8-10 reflects high self-efficacy based on Bandura's theory of self-efficacy.
12 months after initial primary care visit
Changes in Systolic Blood Pressure
Prazo: 12 months after the initial primary care visit
changes in systolic blood pressure (BP) from enrollment to 12 months
12 months after the initial primary care visit
Changes in Diastolic Blood Pressure
Prazo: 12 months after the initial primary care visit
changes in diastolic blood pressure (BP) from enrollment to 12 months
12 months after the initial primary care visit
Changes in Total Cholesterol
Prazo: 12 months after the initial primary care visit
changes in total cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in HDL Cholesterol
Prazo: 12 months after the initial primary care visit
changes in HDL cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in LDL Cholesterol
Prazo: 12 months after the initial primary care visit
changes in LDL cholesterol from Enrollment to 12 Months
12 months after the initial primary care visit
Changes in Triglycerides
Prazo: 12 months after the initial primary care visit
changes in triglycerides from enrollment to 12 months
12 months after the initial primary care visit
Changes in HbA1c Levels
Prazo: 12 months after the initial primary care visit
changes in Hemoglobin (HbA1c) levels from enrollment to 12 months
12 months after the initial primary care visit
Changes in Weight-related Quality of Life Assessed by the Impact of Weight on Quality of Life (IWQOL)-Lite Questionnaire
Prazo: 12 months after the initial primary care visit
Weight-related quality of life will be assessed using the Impact of Weight of Quality of Life (IWQOL)-Lite questionnare. The IWQOL-Lite is a brief, 31-item self-report measure that consists of scores on five scales (physical function, self-esteem, sexual life, public distress, and work) and a total score (sum of scale scores). Participants are asked to rate items with respect to the past week, with responses from "never true" to "always true". Total scores range from 0 (worst possible quality of life) to 100 (best possible quality of life).
12 months after the initial primary care visit
Changes in Percentage of Patients Reporting Excellent/Very Good Health Status Assessed by Using a 5-point Scale Questionnaire From the 36-Item Short Form Health Survey(SF-36)
Prazo: 12 months after the initial primary care visit
Health status will be assessed using 5-point scale response to a single question from the SF-36, "In general, would you say that your health is...(1=Excellent, 2=Very Good, 3=Good, 4=Fair, 5=Poor"). A higher score indicates a worse outcome (5= poor health status).
12 months after the initial primary care visit
Changes in Self-reported Physical Activity
Prazo: 12 months after the initial primary care visit
changes in self-reported physical activity minutes per week
12 months after the initial primary care visit
Changes in Diet, Specifically Fruits/Vegetables, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically fruits/vegetables as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Whole Grains, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically whole grains as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Sugar-sweetened Beverages, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically sugar-sweetened beverages as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Baked Products, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically baked products as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Processed Meats, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically processed meats as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit
Changes in Diet, Specifically Fried Foods, as Measured by the PrimeScreen Questionnaire
Prazo: 12 months after the initial primary care visit
changes in diet, specifically fried foods as measured by the PrimeScreen questionnaire, a brief dietary screening tool.
12 months after the initial primary care visit

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Heather Baer, ScD, Brigham and Women's Hospital

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

19 de julho de 2016

Conclusão Primária (Real)

8 de novembro de 2018

Conclusão do estudo (Real)

8 de maio de 2019

Datas de inscrição no estudo

Enviado pela primeira vez

4 de janeiro de 2016

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de janeiro de 2016

Primeira postagem (Estimativa)

15 de janeiro de 2016

Atualizações de registro de estudo

Última Atualização Postada (Real)

5 de novembro de 2020

Última atualização enviada que atendeu aos critérios de controle de qualidade

9 de outubro de 2020

Última verificação

1 de outubro de 2020

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2015P002372

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Não

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever